Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Pharm ; 601: 120581, 2021 May 15.
Article in English | MEDLINE | ID: mdl-33839228

ABSTRACT

A Near Infrared (NIR) method was developed using a small benchtop feed frame system to quantify Saccharin potency in a powder blend during continuous manufacturing process. A 15-point Design of Experiments (DoE) was created based on the NIR spectral response and compositions of the formulation to develop a calibration set. The calibration set was designed to create compositional and raw material lots variation using minimum resources. The calibration experiments utilized around 0.5 kg Saccharin (Active Pharmaceutical Ingredient (API) surrogate) and 1.8 kg of excipients. Partial Least Square (PLS) modeling was used to develop a quantitative NIR method from the calibration data. The NIR method was implemented during 5 test batches in two different manufacturing sites across different potency levels at a continuous manufacturing platform for direction compression. Acceptable prediction performance was achieved from the NIR method at both sites. The NIR method was robust against changes in process scale and NIR instruments. The variance information built into the calibration set was found to be critical to successful model performance. This study shows a benchtop feed frame can be used for material sparing calibration method development without operating at a full-scale process line and applied across multiple sites, instruments at different potency levels.


Subject(s)
Excipients , Spectroscopy, Near-Infrared , Calibration , Drug Compounding , Least-Squares Analysis , Powders , Tablets , Technology, Pharmaceutical
2.
J Pharm Biomed Anal ; 70: 273-9, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22871426

ABSTRACT

Infrared spectroscopy is used to monitor the dissolution of the Active Pharmaceutical Ingredient (API) and an excipient (vitamin E - TPGS) during manufacturing of a liquid pharmaceutical formulation. The goal of the analysis is to explore options for real-time, on screen, and quantitative monitoring of these two components by using an iC10 instrument. As is common, the first step in the approach is to create respective calibration models for the two components and then apply those models on the spectra obtained from scale-up batches. Interestingly, while the API dissolves at the room temperature, TPGS dissolves at an acceptable rate at 50 °C so both temperatures have to be considered. It is shown that univariate models of sufficient accuracy can be developed with a straightforward applicability to the scale-up batches spectra and providing reasonably accurate estimates of the API and TPGS concentrations. Some limitations of the software on the employed instrument may diminish the prospect for the quantitative analysis of the components of interest in this formulation.


Subject(s)
Excipients/chemistry , Spectroscopy, Fourier Transform Infrared , Technology, Pharmaceutical/methods , Vitamin E/analogs & derivatives , Calibration , Chemistry, Pharmaceutical , Computer Systems , Dosage Forms , Models, Chemical , Online Systems , Polyethylene Glycols/chemistry , Reference Standards , Software , Solubility , Spectroscopy, Fourier Transform Infrared/standards , Technology, Pharmaceutical/standards , Temperature , Vitamin E/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...